Lille, France

Clément Danis

This inventor holds 1 USPTO granted patent. Top assignees: Centre National De La Recherche Scientifique, Lille University Hospital, National Institute of Health and Medical Research. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Clément Danis. Retrieved from https://idiyas.com/inventor/clément-danis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Clément Danis: Innovator in Antibody Research

Introduction

Clément Danis is a notable inventor based in Lille, France. He has made significant contributions to the field of antibody research, particularly with his innovative patent.

Latest Patents

Clément Danis holds a patent for a "New Anti Tau SVQIVYKPV Epitope Single Domain Antibody." This invention showcases his expertise in developing targeted therapies that could have implications in treating neurodegenerative diseases.

Career Highlights

Throughout his career, Clément has worked with prestigious institutions such as the National Institute of Health and Medical Research and the Centre National de la Recherche Scientifique (CNRS). His work in these organizations has allowed him to advance his research and contribute to the scientific community.

Collaborations

Clément has collaborated with esteemed colleagues, including Luc Buee and Isabelle Landrieu. These partnerships have enriched his research and fostered innovation in the field.

Conclusion

Clément Danis is a prominent figure in antibody research, with a patent that highlights his innovative spirit and dedication to advancing medical science. His contributions continue to influence the field and inspire future research endeavors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…